Strep Throat Treatment Market Players:
- Pfizer Inc.
- Company Overview
- Business Planning
- Main Product Offerings
- Financial Execution
- Main Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Astrazeneca
- Novartis AG
- Bayer AG
- GSK Plc.
- Melinta Therapeutics
- Amgen Inc.
- Teva Pharmaceutical Industries Ltd.
- Merck & co, Inc.
- Johnson & Johnson Service, Inc.
- Takeda Pharmaceutical Company Limited
- Sanofi
- Mitsubishi Chemical Group Corp.
- Daiichi Sankyo Co Ltd.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of strep throat treatment is estimated at USD 2.37 billion.
The global strep throat treatment market size crossed USD 2.28 billion in 2025 and is likely to expand at a CAGR of more than 4.3%, surpassing USD 3.47 billion revenue by 2035.
North America strep throat treatment market will dominate around 38% share by 2035, fueled by rising advancements in technology in the region.
Key players in the market include Pfizer Inc., Astrazeneca, Novartis AG, Bayer AG, GSK plc., Melinta Therapeutics, Amgen Inc., Teva Pharmaceutical Industries Ltd., Merck & co, Inc., Johnson & Johnson Service, Inc., Takeda Pharmaceutical Company Limited, Sanofi, Mitsubishi Chemical Group Corp., Daiichi Sankyo Co Ltd.
